Captrust Financial Advisors Deciphera Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $166,451 - $272,314	16,464 New	16,464 $265,000
Q2 2022 Aug 23, 2022	SELL	$9.11 - $13.98 $2,286 - $3,508	-251 Reduced 19.46%	1,039 $14,000
Q2 2022 Aug 16, 2022	BUY	$9.11 - $13.98 $4,718 - $7,241	518 Added 67.1%	1,290 $17,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $2,720 - $4,399	-396 Reduced 33.9%	772 $7,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $2,987 - $14,406	388 Added 49.74%	1,168 $11,000
Q3 2021 Nov 16, 2021	BUY	$26.46 - $37.15 $8,837 - $12,408	334 Added 74.89%	780 $27,000
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $163 - $239	5 Added 1.13%	446 $16,000
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $17,811 - $25,017	441 New	441 $20,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.